As a pediatric oncologist, I specialize in treating pediatric leukemia and lymphoma, emphasizing the use of cellular therapy. Cellular therapy involves modifying a patient’s own cells or cells from a donor to fight disease.
I have long been inspired by the strength and bravery of children going through cancer diagnosis and treatment. It is an incredibly difficult process. I'm passionate about providing longitudinal care while guiding patients and their families through this challenging time. I strive to treat every patient I meet with the utmost respect, care, patience, honesty and dedication.
My research focuses on using new and emerging cellular therapy techniques to better treat difficult-to-manage leukemias and lymphomas and the management of important side effects such as viral infections. I am the recipient of a St. Baldrick's Fellow research grant from July 2020 to July 2022, looking at the use of T-cell therapy to prevent viral infections.
I love to spend my free time with my wife, son and daughter. I also like to run, read books and play basketball.
Pediatric hematology/oncology; leukemia, sarcoma, cellular therapies
Viral infections are a significant source of morbidity and mortality in patients following hematopoietic stem cell transplant and antiviral medications carry high toxicity profiles often with suboptimal response. They have a phase I/II study investigating the use of engineered viral specific T-cells in treating these viral infections. Dr. Rubinstein's research is focusing on better characterizing the immunologic features of these cell lines with the goal of more accurately predicting which cell line will work for which patient.
Assistant Professor, UC Department of Pediatrics
Cancer and Blood Diseases